Search - tctmd.com

Displaying 841 - 860 of 1004

Sort: Relevancy | Date

News Daily News

Stent Malapposition Frequent, But Without Clinical Consequences

Jason Kahn

January 27, 2014

News Daily News

La Mala Aposición del Stent es algo Frecuente que No tiene Consecuencias Clínicas

Jason Kahn

January 27, 2014

News Daily News

TAVR-Linked Conduction Abnormality Worsens Functional Status, but Not Mortality

Jason Kahn

January 16, 2014

News Daily News

ESC Statement Cautions Against Radiation Overuse in Cardiac Procedures

January 13, 2014

News Daily News

IVUS Guidance Reduces Stent Thrombosis, MACE Compared to Angiography

December 08, 2013

News Daily News

SCAI Paper Outlines ‘Best Practices’ for FFR, IVUS, OCT

Yael L. Maxwell

November 14, 2013

News Daily News

FFR-Guided PCI Shows Differences in Long-Term Outcomes in Men, Women

Yael L. Maxwell

November 14, 2013

News Conference News TCT 2013

Ultrasound Optimizes Radial Access in Randomized Trial

November 06, 2013

News Daily News

研究结果支持ACS患者的DAPT治疗持续3个月以上

L.A. McKeown

November 01, 2013

News Daily News

Los Hallazgos avalan una Duración de la Terapia Antiplaquetaria Doble mayor que 3 Meses en Pacientes SCA

L.A. McKeown

November 01, 2013

News Daily News

Findings Support DAPT Duration Longer Than 3 Months in ACS Patients

L.A. McKeown

November 01, 2013

Presentation TCT 2013

Shorter Is Better: New Insights From OPTIMIZE, PARIS, and Other Studies

Presenter: Roxana Mehran

October 31, 2013

Presentation TCT 2013

OPTIMIZE and ARTIC-INTERRUPTION: Perspectives on DAPT Duration after PCI

Presenter: Peter Wenaweser

October 31, 2013

Presentation TCT 2013

Featured Trial of the Day: OPTIMIZE: A Prospective, Randomized Trial of Three Months vs. 12 Months of Dual Antiplatelet Therapy After PCI

Presenter: Fausto Feres

October 31, 2013

Presentation TCT 2013

Supersaturated Oxygen Therapy: From AMIHOT-II to Optimized SSO2

Presenter: Shukri David

October 31, 2013

News Conference News TCT 2013

OPTIMIZE: 3-Month DAPT Safe with ZES

October 31, 2013

News Industry News

New Study Demonstrates Potential Benefits of Shorter-Term Dual Antiplatelet Therapy in Patients Treated With a Second Generation Drug-Eluting Stent

October 31, 2013

Presentation TCT 2013

Optimized Medical Therapy for the PAD Patient, With or Without Intervention

Presenter: Michael Jaff

October 30, 2013

Presentation TCT 2013

TCT-84. Fractional Flow Reserve versus Angiography in Guiding Management to Optimize Outcomes in Non-ST Elevation Myocardial Infarction (FAMOUS – NSTEMI) Clinical Trial: Study...

Presenter: Colin Berry

October 29, 2013

Presentation TCT 2013

TCT-82. Fractional Flow Reserve versus Angiography in Guiding Management to Optimize Outcomes in Non-ST Elevation Myocardial Infarction (FAMOUS – NSTEMI) Clinical Trial:...

Presenter: Colin Berry

October 29, 2013

Advertisement

Stent Malapposition Frequent, But Without Clinical Consequences

La Mala Aposición del Stent es algo Frecuente que No tiene Consecuencias Clínicas

TAVR-Linked Conduction Abnormality Worsens Functional Status, but Not Mortality

ESC Statement Cautions Against Radiation Overuse in Cardiac Procedures

IVUS Guidance Reduces Stent Thrombosis, MACE Compared to Angiography

SCAI Paper Outlines ‘Best Practices’ for FFR, IVUS, OCT

FFR-Guided PCI Shows Differences in Long-Term Outcomes in Men, Women

Ultrasound Optimizes Radial Access in Randomized Trial

研究结果支持ACS患者的DAPT治疗持续3个月以上

Los Hallazgos avalan una Duración de la Terapia Antiplaquetaria Doble mayor que 3 Meses en Pacientes SCA

Findings Support DAPT Duration Longer Than 3 Months in ACS Patients

Shorter Is Better: New Insights From OPTIMIZE, PARIS, and Other Studies

OPTIMIZE and ARTIC-INTERRUPTION: Perspectives on DAPT Duration after PCI

Featured Trial of the Day: OPTIMIZE: A Prospective, Randomized Trial of Three Months vs. 12 Months of Dual Antiplatelet Therapy After PCI

Supersaturated Oxygen Therapy: From AMIHOT-II to Optimized SSO2

OPTIMIZE: 3-Month DAPT Safe with ZES

New Study Demonstrates Potential Benefits of Shorter-Term Dual Antiplatelet Therapy in Patients Treated With a Second Generation Drug-Eluting Stent

Optimized Medical Therapy for the PAD Patient, With or Without Intervention

TCT-84. Fractional Flow Reserve versus Angiography in Guiding Management to Optimize Outcomes in Non-ST Elevation Myocardial Infarction (FAMOUS – NSTEMI) Clinical Trial: Study...

TCT-82. Fractional Flow Reserve versus Angiography in Guiding Management to Optimize Outcomes in Non-ST Elevation Myocardial Infarction (FAMOUS – NSTEMI) Clinical Trial:...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content